Cancer Family
Malignant Head and Neck Neoplasm
CI-CAN-00000236Explore in graph →
1,432 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000236Explore in graph →
Clinical trials
5,449 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (629)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00148122 | A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck Cancer | completed | Phase 2 | 40 | University of Michigan Rogel Cancer CenterOTHER | 1 | Apr 17, 2014 | clinicaltrials |
| NCT01937793 | Swallowing Exercises for Nasopharyngeal Cancer After Radiation Therapy | completed | N/A | 16 | National Taiwan University HospitalOTHER | 1 | Apr 17, 2014 | clinicaltrials |
| NCT01439724 | Low-level Laser Therapy to Prevent Oral Mucositis in Head and Neck Patients | completed | Phase 3 | 94 | Instituto Nacional de Cancer, BrazilOTHER_GOV | 1 | Apr 11, 2014 | clinicaltrials |
| NCT01358097 | Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy | completed | — | 33 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Apr 10, 2014 | clinicaltrials |
| NCT00223158 | Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer | completed | N/A | 70 | Patrice PerronOTHER | 1 | Apr 9, 2014 | clinicaltrials |
| NCT00971932 | Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) | completed | Phase 2 | 33 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Apr 8, 2014 | clinicaltrials |
| NCT00589667 | A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC) | completed | Phase 2 | 26 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 2, 2014 | clinicaltrials |
| NCT00959387 | Induction Chemotherapy for Advanced Head and Neck Cancer | completed | Phase 2 | 60 | Barretos Cancer HospitalOTHER | 1 | Mar 26, 2014 | clinicaltrials |
| NCT01712919 | Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC) | completed | Phase 1 / Phase 2 | 61 | Jiangsu Cancer Institute & HospitalOTHER | 1 | Mar 24, 2014 | clinicaltrials |
| NCT01840332 | Method of Endogenous TSH Stimulation in the Follow-up of Differentiated Thyroid Cancer | completed | N/A | 20 | University of TartuOTHER | 1 | Mar 14, 2014 | clinicaltrials |
| NCT00865098 | Study of Cetuximab With Concomitant-boost Radiotherapy in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) | completed | Phase 2 | 27 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Mar 12, 2014 | clinicaltrials |
| NCT02073032 | Incidence and Risk Factors of Refeeding Syndrome | completed | — | 79 | University of CopenhagenOTHER | 1 | Feb 27, 2014 | clinicaltrials |
| NCT00316823 | Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules | completed | N/A | 400 | University of California, San FranciscoOTHER | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00061906 | Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer | completed | Phase 2 | 25 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Feb 11, 2014 | clinicaltrials |
| NCT00526851 | Oral Cancer Screening Among Nursing Home Dentists in Ohio | completed | — | 37 | Case Comprehensive Cancer CenterOTHER | 1 | Feb 5, 2014 | clinicaltrials |
| NCT01354639 | Comparative Study of Surgical Completeness After Robotic Thyroidectomy Versus Conventional Open Thyroidectomy | completed | — | 150 | Yonsei UniversityOTHER | 1 | Feb 5, 2014 | clinicaltrials |
| NCT02055989 | A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and Hypopharynx | completed | Phase 1 / Phase 2 | 105 | Royal Marsden NHS Foundation TrustOTHER | 1 | Feb 5, 2014 | clinicaltrials |
| NCT01252498 | Evaluation of the Role of Prostaglandins in Radiation-induced Mucositis | completed | — | 9 | University of VermontOTHER | 1 | Feb 4, 2014 | clinicaltrials |
| NCT01255800 | Pilot Study of Cetuximab and the Hedgehog Inhibitor IPI-926 in Recurrent Head and Neck Cancer | completed | Phase 1 | 9 | University of Colorado, DenverOTHER | 1 | Jan 31, 2014 | clinicaltrials |
| NCT02049112 | A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study(NIAGARA) | completed | Phase 4 | 210 | Unither Pharmaceuticals, FranceINDUSTRY | 1 | Jan 29, 2014 | clinicaltrials |
| NCT00002496 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx | completed | Phase 3 | — | Radiation Therapy Oncology GroupNETWORK | 2 | Jan 24, 2014 | clinicaltrials |
| NCT00002670 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery | completed | Phase 3 | 459 | Radiation Therapy Oncology GroupNETWORK | 2 | Jan 24, 2014 | clinicaltrials |
| NCT00771641 | Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck | completed | Phase 3 | 1,113 | Radiation Therapy Oncology GroupNETWORK | 0 | Jan 24, 2014 | clinicaltrials |
| NCT00791141 | Adjuvant Cetuximab and Chemoradiation in Head and Neck Cancer(ACCRA-HN) | completed | Phase 2 | 80 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Jan 23, 2014 | clinicaltrials |
| NCT01433809 | Biomarkers to Distinguish Benign From Malignant Thyroid Neoplasm | completed | — | 1 | Norman EberhardtOTHER | 1 | Jan 22, 2014 | clinicaltrials |
| NCT00203905 | A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck | completed | Phase 2 | 23 | University of ChicagoOTHER | 1 | Jan 17, 2014 | clinicaltrials |
| NCT00718770 | A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression | completed | Early Phase 1 | 10 | University of Colorado, DenverOTHER | 1 | Jan 17, 2014 | clinicaltrials |
| NCT00098631 | Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer | completed | Phase 2 | 88 | National Cancer Institute (NCI)NIH | 1 | Jan 7, 2014 | clinicaltrials |
| NCT01268878 | Hematologic Toxicity Observation of the Docetaxel+ Cisplatin+ Fluorouracil (TPF)Medical Protocol(OTOHTPF) | completed | — | 130 | Groupe Oncologie Radiotherapie Tete et CouOTHER | 1 | Jan 3, 2014 | clinicaltrials |
| NCT02024035 | Protocole Advanced RadioTherapy ORL(ART-ORL) | completed | — | 180 | Centre Leon BerardOTHER | 1 | Dec 31, 2013 | clinicaltrials |
| NCT00003576 | Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery | completed | Phase 3 | 200 | National Cancer Centre, SingaporeOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00004062 | Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer | completed | Phase 1 | — | Lucille P. Markey Cancer Center at University of KentuckyOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00334997 | Endoscopic Surgery or Radiation Therapy in Treating Patients With Stage 0, Stage I, or Stage II Laryngeal Cancer of the Glottis | completed | Phase 2 | 50 | University College London HospitalsOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT01865201 | Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis | completed | Phase 2 | 154 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Dec 12, 2013 | clinicaltrials |
| NCT00055770 | Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer | completed | Phase 1 / Phase 2 | 45 | National Cancer Institute (NCI)NIH | 1 | Nov 25, 2013 | clinicaltrials |
| NCT00008398 | Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer | completed | Phase 3 | — | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 19, 2013 | clinicaltrials |
| NCT00095875 | Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial) | completed | Phase 3 | 145 | Dana-Farber Cancer InstituteOTHER | 2 | Nov 19, 2013 | clinicaltrials |
| NCT01172769 | Efficacy Study of Temsirolimus to Treat Head and Neck Cancer(TEMHEAD) | completed | Phase 2 | 42 | Hannover Medical SchoolOTHER | 1 | Nov 8, 2013 | clinicaltrials |
| NCT00004256 | Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer | completed | Phase 2 | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT01184482 | Lapatinib and Cetuximab in Patients With Solid Tumors(TYKERB-ITUX 1) | completed | Phase 1 | 22 | Georgetown UniversityOTHER | 1 | Oct 31, 2013 | clinicaltrials |
| NCT01596868 | GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest China | completed | Phase 2 | 60 | Air Force Military Medical University, ChinaOTHER | 1 | Oct 30, 2013 | clinicaltrials |
| NCT00620139 | Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma | completed | — | 17 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 24, 2013 | clinicaltrials |
| NCT00382031 | Zalutumumab in Patients With Non-curable Head and Neck Cancer | completed | Phase 3 | 286 | GenmabINDUSTRY | 12 | Oct 15, 2013 | clinicaltrials |
| NCT00121628 | A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer | completed | Phase 2 | 184 | AmgenINDUSTRY | 0 | Oct 9, 2013 | clinicaltrials |
| NCT00085371 | Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas | completed | Phase 2 | 116 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00526149 | BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | completed | Phase 2 | 76 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Oct 7, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00049166 | Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer | completed | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00847509 | A Multi - Center Study Of PET Imaging With [F-18] FLT & [F-18] FDG in Cancer Patients for Treatment Evaluation(FLT101) | completed | N/A | 49 | Siemens Molecular ImagingINDUSTRY | 1 | Sep 27, 2013 | clinicaltrials |
| NCT01100619 | A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors | completed | Phase 1 | 40 | ExelixisINDUSTRY | 1 | Sep 19, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Apr 17, 2014source: clinicaltrials